Improvement in liver histology with obeticholic acid in patients with nonalcoholic steatohepatitis and type 2 diabetes

被引：0
|
作者：
Liberman, A. [1 ]
McCullough, A. [2 ]
Neuschwander-Tetri, B. [3 ]
Sanyal, A. [4 ]
Abdelmalek, M. [5 ]
Gogineni, R. [1 ]
Ferguson, B. [1 ]
Shringarpure, R. [1 ]
Shapiro, D. [1 ]
机构：
[1] Intercept Pharmaceut Inc, San Diego, CA USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] St Louis Univ, Hlth Sci Ctr, St Louis, MO 63103 USA
[4] Virginia Commonwealth Univ, Richmond, VA 23284 USA
[5] Duke Univ, Sch Med, Durham, NC 27706 USA
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1247
引用
收藏
页码：S574 / S574
页数：1
相关论文
共 50 条
  • [41] Liver Histology and Clinical Trials for Nonalcoholic Steatohepatitis-Perspectives From 2 Pathologists
    Kleiner, David E.
    Bedossa, Pierre
    GASTROENTEROLOGY, 2015, 149 (06) : 1305 - 1308
  • [42] Clinical and Metabolic Effects Associated With Weight Loss and Obeticholic Acid In Nonalcoholic Steatohepatitis (NASH)
    Hameed, Bilal
    Terrault, Norah
    Gill, Ryan M.
    Loomba, Rohit
    Chalasani, Naga P.
    Hoofnagle, Jay H.
    Van Natta, Mark L.
    HEPATOLOGY, 2015, 62 : 331A - 331A
  • [43] Obeticholic Acid Was Safe and Well Tolerated in Patients with Nonalcoholic Steatohepatitis and Compensated Cirrhosis: A Secondary Analysis of the Control Study
    Halegoua-De Marzio, Dina
    Thuluvath, Paul J.
    Abdelmalek, Manal F.
    Van Biene, Courtney
    Shringarpure, Reshma
    MacConell, Leigh
    HEPATOLOGY, 2018, 68 : 45A - 45A
  • [44] Erratum: miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice
    Pedro M Rodrigues
    Marta B Afonso
    André L Simão
    Catarina C Carvalho
    Alexandre Trindade
    António Duarte
    Pedro M Borralho
    Mariana V Machado
    Helena Cortez-Pinto
    Cecília MP Rodrigues
    Rui E Castro
    Cell Death & Disease, 2017, 8 : e2825 - e2825
  • [45] Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis
    Younossi, Zobair M.
    Stepanova, Maria
    Nader, Fatema
    Loomba, Rohit
    Anstee, Quentin M.
    Ratziu, Vlad
    Harrison, Stephen
    Sanyal, Arun J.
    Schattenberg, Jorn M.
    Barritt, A. Sidney
    Noureddin, Mazen
    Bonacci, Martin
    Cawkwell, Gail
    Wong, Bruce
    Rinella, Mary
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (09) : 2050 - +
  • [46] Obstructive Sleep Apnea Is Associated with Nonalcoholic Steatohepatitis and Advanced Liver Histology
    Corey, Kathleen E.
    Misdraji, Joseph
    Gelrud, Lou
    King, Lindsay Y.
    Zheng, Hui
    Malhotra, Atul
    Chung, Raymond T.
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (08) : 2523 - 2528
  • [47] Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis
    Targher, Giovanni
    Bertolini, Lorenzo
    Rodella, Stefano
    Lippi, Giuseppe
    Zoppini, Giacomo
    Chonchol, Michel
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (12): : 2166 - 2171
  • [48] NONALCOHOLIC STEATOHEPATITIS (NASH) TREATMENT INVOLVING IMPROVEMENT IN LIVER TISSUE FATTY ACID COMPOSITION
    Shimada, Masahiko
    Yoshida, Shuhei
    Yoshino, Morihiko
    HEPATOLOGY, 2009, 50 (04) : 774A - 775A
  • [49] NGM282 Improves Liver Fibrosis and Histology in 12 Weeks in Patients With Nonalcoholic Steatohepatitis
    Harrison, Stephen A.
    Rossi, Stephen J.
    Paredes, Angelo H.
    Trotter, James F.
    Bashir, Mustafa R.
    Guy, Cynthia D.
    Banerjee, Rajarshi
    Jaros, Mark J.
    Owers, Sandra
    Baxter, Bryan A.
    Ling, Lei
    DePaoli, Alex M.
    HEPATOLOGY, 2020, 71 (04) : 1198 - 1212
  • [50] Safety, Pharmacokinetics and Pharmacodynamics of Obeticholic Acid in Subjects with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
    Alkhouri, Naim
    Edwards, Jeffrey
    Poordad, Fred
    Lawitz, Eric J.
    Lee, Lois
    Karan, Sharon B.
    Campagna, Jason
    MacConell, Leigh
    HEPATOLOGY, 2018, 68 : 974A - 974A
12345